Michael Roth

Michael Roth is a Senior Professor at The University of Texas MD Anderson Cancer Center. His research focuses on adolescent and young adult oncology, hematologic malignancies, and cancer care delivery, with particular emphasis on clinical trial enrollment, patient-reported outcomes, and health insurance disparities. His recent work includes population-based analyses of Children’s Oncology Group trial enrollment, post-transplant maintenance therapy with revumenib for KMT2Ar acute leukemia, and mixed-methods studies on young adult cancer survivors’ experiences with insurance coverage and advanced cancer decision-making. He has published extensively in journals such as JNCI, Blood Advances, and the Journal of Clinical Oncology, contributing to national efforts to improve outcomes and care quality for adolescents and young adults with cancer.